Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more) Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more) Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > Listened to 2 PDT talks
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(298)
•••
Comment by fredgoodwinsonon Nov 05, 2020 1:11pm
152 Views
Post# 31842904

RE:RE:RE:RE:Listened to 2 PDT talks

RE:RE:RE:RE:Listened to 2 PDT talks

Much obliged Enrique.

 

Dr.Lilge was scheduled to speak at 1530hrs local on ‘PDT dosimetry approaches for peripheral Lung Cancer. Preclinical studies’ followed immediately by Sarah Chamberlain with ‘Pretreatment Plan Development for Intraoperative Photodynamic Therapy at 1545hrs.

 

Dr.Lilge was then scheduled to speak again on Interstitial PDT.

 

Roswell Park have a sophisticated equivalent of Interstitial PDT in the Lumeda OSA/Digilum which they are likely to use with TLD-1433 in Lung Cancer but Theralase look more likely - at least currently - to be investigating Rutherrin plus low dose X-Ray.

 

Did Dr.Lilge make clear whether those dosimetry approaches related to any particular or more than one particular means of activation?

 

Thanks,

 

Fred

 

 

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities